Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis

Abstract

Both BP and PF stents have a 1-year safety profile similar to that of the PP stent. Whereas the PF stent provided an inferior efficacy, the BP stent is at least as effective as the PP stent in terms of anti-restenotic efficacy.